We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+9.7%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$6.58B
AUM Growth
-$16.9M
Cap. Flow
-$345M
Cap. Flow %
-5.24%
Top 10 Hldgs %
19.23%
Holding
670
New
207
Increased
92
Reduced
126
Closed
222

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$119M
2
ADI icon
Analog Devices
ADI
+$91.5M
3
PAYC icon
Paycom
PAYC
+$76.8M
4
PANW icon
Palo Alto Networks
PANW
+$71M
5
AZEK
The AZEK Co
AZEK
+$59.1M

Top Sells

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$142M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$122M
3
CRM icon
Salesforce
CRM
+$101M
4
PFPT
Proofpoint, Inc.
PFPT
+$80.9M
5
TWLO icon
Twilio
TWLO
+$72M

Sector Composition

Rank Sector Weight
1 Technology 22.89%
2 Healthcare 14.97%
3 Industrials 11.6%
4 Consumer Discretionary 11.16%
5 Financials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWOU
376
DELISTED
2U Inc
TWOU
$1.34M 0.02%
+1,321
New +$1.57M
EW icon
377
Edwards Lifesciences
EW
$53.8B
$1.22M 0.02%
+15,236
New +$1.19M
FHI icon
378
Federated Hermes
FHI
$4.75B
$1.21M 0.02%
+56,254
New +$1.33M
VITL icon
379
Vital Farms
VITL
$498M
$1.21M 0.02%
+29,755
New +$1.12M
NBIS
380
Nebius Group N.V.
NBIS
$48.2B
$1.13M 0.02%
17,382
-57,445
-77% -$3.42M
TSHA icon
381
Taysha Gene Therapies
TSHA
$1.84B
$1.13M 0.02%
+50,400
New +$1.19M
SPRO icon
382
Spero Therapeutics
SPRO
$70.6M
$1.12M 0.02%
+100,000
New +$1.18M
CLX icon
383
Clorox
CLX
$13.1B
$1.1M 0.02%
+5,235
New +$1.17M
KTOS icon
384
Kratos Defense & Security Solutions
KTOS
$11.8B
$1.09M 0.02%
56,425
-667,604
-92% -$12.3M
GTH
385
DELISTED
Genetron Holdings Limited ADS
GTH
$1.08M 0.02%
30,240
– –
RGLD icon
386
Royal Gold
RGLD
$19.8B
$1.08M 0.02%
+9,000
New +$1.18M
CRDF icon
387
Cardiff Oncology
CRDF
$78.6M
$1.06M 0.02%
+75,000
New +$495K
IBP icon
388
Installed Building Products
IBP
$6.39B
$1.05M 0.02%
10,325
-6,540
-39% -$561K
FTOCU
389
DELISTED
FTAC Olympus Acquisition Corp. Unit
FTOCU
$1M 0.02%
+100,002
New +$1,000K
MIRM icon
390
Mirum Pharmaceuticals
MIRM
$6.09B
$963K 0.01%
49,978
-38,406
-43% -$824K
CALC icon
391
CalciMedica
CALC
$10.6M
$961K 0.01%
+5,400
New +$1.13M
RPAY icon
392
Repay Holdings
RPAY
$317M
$948K 0.01%
40,333
-126,727
-76% -$3.07M
OPTU
393
Optimum Communications Inc
OPTU
$312M
$947K 0.01%
+36,442
New +$946K
CNST
394
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$911K 0.01%
44,973
+25,000
+125% +$610K
FUSN
395
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$909K 0.01%
75,600
– –
FEAC.WS
396
DELISTED
Flying Eagle Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A com
FEAC.WS
$898K 0.01%
+73,871
New +$266K
KALA icon
397
KALA BIO
KALA
$14.9M
$896K 0.01%
48
+4
+9% +$91.9K
EQ icon
398
Equillium
EQ
$134M
$883K 0.01%
153,091
-97,816
-39% -$792K
PAND
399
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$860K 0.01%
+75,000
New +$1.28M
QS icon
400
QuantumScape Corp
QS
$3.91B
$838K 0.01%
+50,000
New +$741K
14 15
16
17 18

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
PPF
PFA Pension Forsikringsaktieselskab Copenhagen $33.2B AUM

Alyeska Investment Group's Q3 2020 Portfolio in Review

As of Q3 2020, Alyeska Investment Group held 670 positions worth $6.58B, down 0.26% from $6.59B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Alyeska Investment Group withdrew a net $345M in Q3 2020, closing 222 positions and reducing 126 holdings. Its most notable exit was Texas Instruments, an estimated $142M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in Microsoft worth $119M.

  • Alyeska Investment Group's largest Q3 2020 buy was Microsoft: 568,147 shares worth $119M.
  • Alyeska Investment Group added most to Paycom in Q3 2020, an estimated $76.8M increase.
  • Alyeska Investment Group's biggest Q3 2020 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Alyeska Investment Group fully exited Texas Instruments in Q3 2020, selling an estimated $142M.
  • Alyeska Investment Group's ten largest holdings make up 19% of its $6.58B portfolio in Q3 2020.
  • Alyeska Investment Group opened 207 new positions and closed 222 in Q3 2020.
  • Alyeska Investment Group's portfolio value fell 0.26% quarter-over-quarter to $6.58B.

Based on Alyeska Investment Group's 13F filing for Q3 2020, filed 16 Nov 2020.